We are in pursuit of identifying and developing life-saving solutions for global healthcare problems with a focus on cancer diagnostics and cure.
Trusted by:
11000+
Patients Served
450+
Doctors Trust Us
100+
Publications
13+
Years of Excellence
Why choose us?
Our approach is grounded in rigorous research, advanced platforms, and a commitment to meaningful outcomes.
Patented Techologies
Proprietary innovations designed to deliver precision, reliability, and real-world impact.
Regulatory Approved
Regulatory-approved solutions built to meet the highest standards of safety, compliance, and clinical integrity.
Startup Mantra: Making cancer detection more accessible
Founded in 2013 by Jayant Khandare and Aravindan Vasudevan, the company has launched its first product, the ‘OncoDiscover Liquid Biopsy Test’, a minimally invasive test which can be performed multiple times requiring 1.5ml blood volume…
August 6, 2022
Frequently asked questions
Answers to commonly asked questions about Actorius and our offerings.
Actorius focuses on understanding cancer at the cellular level and translating that insight into precise, actionable outcomes. Our platforms are designed to look deeper, act earlier, and support more confident decisions.
Our solutions are built for clinicians, researchers, healthcare partners, and institutions seeking advanced tools for cancer detection, analysis, and monitoring.
We combine advanced biomaterials, biological insight, and data-driven analysis to study cancer behavior in detail—enabling earlier detection and more targeted intervention.
Our work spans both research and translational applications. Some solutions are designed for research use, while others are developed with clinical deployment in mind, subject to regulatory requirements.
You can explore our latest blogs, newsletters, press releases, case studies, and events in the Resources section to stay informed about our progress and insights.
